p53 Mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA)

Journal of Investigative Dermatology

Volumn 109, Issue 2, 1997, Pages 238-243

  Nataraj, Arun J ^a   Wolf, Peter ^b   Cerroni, Lorenzo ^b   Ananthaswamy, Honnavara N ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinogenesis; Mutagenesis; Skin cancer

Indexed keywords

DNA; METHOXSALEN; NUCLEOTIDE; PROTEIN P53; PSORALEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; PUVA; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 0030852181     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12319764     Document Type: Article

References (72)

1. Ananthaswamy HN: Neoplastic transformation of C3H mouse embryo 10T1/2 cells by 8-methoxypsoralen plus UVA radiation. J Invest Dermatol 85:102-106, 1985
2. Ashwood-Smith MJ, Poulton G, Barker M, Mildenberger M: 5-Methoxypsoralen, an ingredient in several suntan preparations, has lethal, mutagenic and clastogenic properties. Nature 285:407-409, 1980
3. Ben-Hur E, Elkind MM: DNA cross-linking in Chinese hamster cells exposed to near ultraviolet light in the presence of 4,5,8-trimethylpsoralen. Biochim Biophys Acta 331:181-193, 1973
4. Boyer V, Moustacchi K, Sage S: Sequence specificity in photoreaction of various psoralen derivatives with DNA: role in biological activity. Biochemistry 27:3011-3018, 1987
5. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128, 1991
6. Bruynzeel I: "High-single dose" European FUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 124:49-55, 1987
7. Campbell C, Quinn AG, Ko YS, Angus B, Rees JL: p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100:746-748, 1993
8. Carraro C, Pathak MA: Studies on the nature of in vitro and in vivo photosensitization reactions by psoralens and porphyrins. J Invest Dermatol 90:267-275, 1991
9. Chiou C-C, Yang J-L: Mutagenicity and specific mutation spectrum induced by 8-methoxypsoralen plus a low dose of UVA in the hprt gene in diploid human fibroblasts. Carcinogenesis 16:1357-1362, 1995
10. Cho Y, Corina S, Jeffrey P, Pavlevitch N: Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355, 1994
11. Cole RS: Inactivation of Escherichia coli, F episomes at transfer and bacteriophage lambda by psoralen plus 360 nm light: significance of deoxyribonucleic acid cross-links. J Bacteriol 107:846-852, 1971
12. Dall'Acqua F: New chemical aspects of photoreaction between psoralen and DNA. In: Castellani A (ed.). Research in Photobiology. Plenum Press, New York, 1977, pp 245-255
13. Diffey BL: The spectral emission from ultraviolet radiation lamps used in dermatology. Photodermatology 3:179-185, 1986
14. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L: Specific UV-induced mutation spectrum in the p53 gene of skin tumors in DNA repair deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 90:10529-10533, 1993
15. Gasparro F, Chan G, Edelson RL: Phototherapy and photopharmacology. Yale J Biol Med 58:519-534, 1985
16. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994
17. Griffin AC: Methoxsalen in ultraviolet carcinogenesis in the mouse. J Invest Dermatol 32:367-372, 1959
18. Gunther EJ, Yeasky TM, Gasparro FP, Glazer PM: Mutagenesis by 8-methoxypsoralen and 5-methylangelicin photoadducts as well as cross-links. Cancer Res 55:1283-1288, 1995
19. Haber LC: Photochemotherapy of psoriasis. N Engl J Med 291:1251-1252, 1974
20. Heller MJ, Burgart LJ, TenEyck CJ, Anderson ME, Greiner TC, Robinson RA: An efficient method for the extraction of DNA from formalin-fixed, paraffin embedded tissue by sonication. Biotechniques 11:372-377, 1991
21. Henseler T, Christopher E, Honnigsmann H, Wolff K: Skin tumors in European PUVA study. J Am Acad Dermatol 16:108-116, 1987
22. Honigsmann H, Fitzpatrick TB, Pathak MA, Wolff K: Oral photochemotherapy with psoralen and UVA (PUVA): principles and practice. In: Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg IM, Austen KF (eds.). Dermatology in General Medicine. McGraw-Hill, New York, 1987, pp 1728-1754
23. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML, Ananthaswamy HN: High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res 53:2961-2964, 1993
24. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwartz M: Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res 52:6400-6403, 1992
25. Kripke ML, Morison WL, Parrish JA: Induction and transplantation of murine skin cancers induced by methoxsalen plus ultraviolet (320-400 nm) radiation. J Natl Cancer Inst 68:685-690, 1982
26. Kripke ML, Morison WL, Parrish JA: Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol 81:87-92, 1983
27. Krueger GG, Bergstresser PR, Nicholas JL, Voorhees JJ: Psoriasis. J Am Acad Dermatol 11:937-947, 1984
28. Kubo Y, Urano Y, Yoshimoto K, Iwahana H, Fukuhara K, Arase S, Itakura M: p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis. J Invest Dermatol 102:440-444, 1994
29. Lever LR, Farr PM: Skin cancers or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 131:215-219, 1994
30. Lindelöf B, Eklund G, Lidén S, Stern RS: The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 22:1056-1060, 1990
31. Lindelöf B, Sigurgeirsson B, Tegner E: PUVA and cancer: a large scale epidemiological study. Lancet 338:91-93, 1991
32. Lindelöf B, Sigurgeirsson B: PUVA and cancer: a case control study. Br J Dermatol 129:39-43, 1993
33. Lindskov R: Skin carcinoma and treatment with photochemotherapy (PUVA). Acta Derm Venereol 63:223-226, 1983
34. Miolo G, Dall'Acqua F, Moustacchi E, Sage E: Monofunctional angular furocoumarins: sequence specificity in DNA photobinding of 6,4,4′-trimethylangelicin and other angelicins. Photothem Photobiol 50:75-84, 1989
35. Moles JP, Moyret C, Guillot B, Jeanteur B: p53 gene mutations in human epithelial skin cancers. Oncogene 8:583-588, 1993a
36. Moles JP, Theillet C, Basset-Seguin N, Guilhou JJ: Mutation of the tumors suppressor gene TP53 is not detected in psoriatic skin. J Invest Dermatol 101:100-102, 1993b
37. Morison WL, Kripke ML: Systemic suppression of contact hypersensitivity by ultraviolet B radiation or methoxsalen/ultraviolet A radiation in the guinea pig. Cell Immunol 85:270-277, 1984
38. Musajo L, Bordin F, Bevilacqua R: Photoreactions at 3655 A linking the 3-4 double bond of furocoumarins with pyrimidine bases. Photochem Photobiol 6:927-931, 1967a
39. Musajo L, Bordin F, Caporale G, Marciani S, Rigatti G: Photoreactions at 3655 A between pyrimidine bases and skin-photosensitizing furocoumarins. Photochem Photobiol 6:711-719, 1967b
40. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK, Yamasaki H: UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 91:360-364, 1994
41. Nataraj AJ, Black HS, Ananthaswamy HN: Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers. Proc Natl Acad Sci USA 93:7961-7965, 1996
42. Nelson MA, Einspar JG, Alberts DS, Balfour CA: Analysis of p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85:23-29, 1994
43. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA: Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N Engl J Med 291:1207-1211, 1974
44. Pathak MA, Daniels F, Hopkins CE, Fitzpatrick TB: Ultraviolet carcinogenesis in albino and pigmented mice receiving furocoumarins, psoralen and 8-methoxypsoralen. Nature 183:728-739, 1959
45. Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN: Mutations in p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog 4:445-449, 1991
46. Potapenko A: Mechanisms of photodynamic effect of furocoumarins. J Photochem Photobiol 9:1-33, 1991
47. Proby CM, Menage HDP, McGregor JM, Hobbs C, Norris PG, Smith N, Hawk JLM, McKee PH: p53 immunoreactivity in cutaneous PUVA tumors is similar to other non-melanoma skin neoplasms. J Cutan Pathol 20:435-441, 1993
48. Rady P, Scinicariello F, Wagner RF, Tyring SK: p53 mutations in basal cell carcinomas. Cancer Res 52:3804-3806, 1992
49. Reid TM, Loeb LA: Tandem double CC→TT mutations are produced by reactive oxygen species. Proc Natl Acad Sci USA 90:3905-3907, 1993
50. Ren ZP, Hedrum A, Ponten F, Nister M, Ahmadian A, Lundeberg J, Uhlen M, Ponten H: Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 12:765-773, 1996
51. Rosenstein BS, Mitchell DL: Action spectra for the induction of pyrimidine (6-4) pyrimidone photoproducts and cyclobutane pyrimidine dimers in normal human skin fibroblasts. Photochem Photobiol 45:775-780, 1987
52. Sage E: Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem Photobiol 57:163-174, 1993
53. Sage E, Bredberg A: Damage distribution and mutation spectrum: the case of 8-methoxypsoralen plus UV-A in mammalian cells. Mutat Res 263:217-222, 1991
54. Sage E, Drobetsky EA, Moustacchi E: 8-Methoxypsoralen-induced mutations are highly targeted at crosslinkable sites of photoaddition on the non-transcribed strand of a mammalian chromosomal gene. EMBO J 12:397-402, 1993
55. Sage E, Moustacchi M: Sequence context on 8-methoxypsoralen photobinding to defined DNA fragments. Biochemistry 26:3307-3314, 1987
56. Sato M, Nishigori C, Zghal M, Yagi T, Takebe H: Ultraviolet-specific mutations in the p53 gene in skin tumors in xeroderma pigmentosum patients. Cancer Res 53:2944-2946, 1993
57. Song PS, Tapley KJ: Photochemistry and photobiology of psoralens. Photochem Photobiol 29:1179-1197, 1979
58. Stern RS: Risks of cancer associated with long-term exposure to PUVA in humans: current status-1991. Blood Cells 18:91-99, 1991
59. Stern RS, Laird N, Melski J: Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 310:1156-1161, 1984
60. Stern RS, Lange R, and Members of the Photochemotherapy Follow-up Study: Nonmelanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 91:120-124, 1988
61. Stern RS, Thibodeau LA, Kleinerman RA: Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 300:800-813, 1979
62. Studniberg HM, Weller P: PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 29:1013-1022, 1993
63. Tanew A, Honigsmann H, Ortel B, Zussner C, Wolff K: Nonmclanoma skin tumors in long-term photochemotherapy treatment of psoriasis. J Am Acad Dermatol 15:960-965, 1986
64. Torinuki W, Tagami H: Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. J Am Acad Dermatol 18:1278-1281, 1988
65. Tornaletti S, Pfeiffer GP: Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263:1436-1438, 1994
66. Van der Riet P, Karp D, Farmer E, Wei Q, Grossman L, Tokino K, Ruppert JM, Sidransky D: Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res 54:25-27, 1994
67. Vos JM, Hanawalt PC.: Processing of psoralen adducts in an active human gene: repair and replication of DNA containing monoadducts and interstrand cross-links. Cell 50:789-799, 1987
68. Weinstein GD, White GM: An approach to the treatment of moderate to severe psoriasis with rotational therapy. J Am Acad Dermatol 28:454-459, 1993
69. Yang S-C, Lin J-G, Chiou C-C, Chen L-Y, Yang J-L: Mutation specificity of 8-methoxypsoralen plus two doses of UVA irradiation in the hprf gene in diploid human fibroblasts. Carcinogenesis 15:201-207, 1994
70. Zarebska Z, Pathak MA, Jarzabek-Chorzelska M, Wolska H, Chorelski T, Jablonska S: Repair of UV-damaged DNA in mammalian skin followed by immunohistochemical method. Acta Biochim Pol 34:93-102, 1987
71. Ziegler A, Jonason AS, Lefell DJ, Simon JA, Sharma HW, Kimmelmann J, Remington L, Jacks T, Brash DE: Sunburn and p53 in the onset of skin cancer. Nature 372:773-776, 1994
72. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Sharma JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90:4216-4220, 1993